Yew Bio Pharm Cash Flow - Annual (OTCMKTS:YEWB)

Add to My Stocks
$0.25 $0.03 (10.92%) YEWB stock closing price Oct 25, 2016 (Closing)

The Yew Bio Pharm cash flow statement helps investors understand how well the company is managing its cash flows. The profit-loss statement shows Yew Bio Pharm profits, the balance sheet shows Yew Bio Pharm debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. This statement can tell if a company is running out of money while still being profitable and is useful in Yew Bio Pharm stock analysis. Yew Bio Pharm had a positive net income cash flow of $5.28M for the latest year. This report is very useful in measuring the short term viability of a company. The cash from operating activities for Yew Bio Pharm is $-1.37MĀ for 2015, which saw a decrease of -133.33% from previous year. View details of Yew Bio Pharm cash flows for latest & last ten financial years.

show more
Get Cash flow for another ticker
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011
Yew Bio Pharm Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow7.74M0.68M0.56M0.56M0.47M
Net Increase (Decrease) in Assets Liabilities-15.43M-1.35M-0.01M-4.59M-0.15M
Cash From (used in) Discontinued Operations-----
Other Adjustments Net1.03M0.5M-2.24M0.01M
Yew Bio Pharm Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.02M--0.29M-0.31M-0.17M
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments-----
Other Cash Inflow (Outflow) from Investment Activities-2.33M-2.44M-3.39M-0.39M-5.51M
Yew Bio Pharm Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares-----
Issuance (Repayment) of Debt Securities-----
Increase (Decrease) in Bank & Other Borrowings3.21M----
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities
Yew Bio Pharm Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.03M-0.01M0.02M0.01M0.11M
Yew Bio Pharm Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year0.48M1.15M0.38M0.73M1.85M
Cash & Equivalents at Year End0.68M0.48M1.15M0.38M0.73M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Yew Bio Pharm stock price history and Yew Bio Pharm stock comparison chart inevitably reflect its cash flow situation.
  • Net Change in Cash and Cash Equivalents: Yew Bio Pharm cash grew YoY to $5.28M, meaning the company is able to meet its expenditure and grow cash which will also eventually reflect in the Yew Bio Pharm stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-1.37M for YEWB.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc. , and was $-1.37M for YEWB in last year report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $3.96M for Yew Bio Pharm.

Key Financial Ratios For Yew Bio Pharm Cash Flow

FCF margin